PC

Pavan Choksi

Investor

United States

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

New York City

  • Min Investment:

    $100,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $1,000,000.00

Skills

Venture Capital
Healthcare
Start-ups
Corporate Development
Strategic Partnerships
Strategy
Entrepreneurship
Business Development
Hospitals
Market Research
Microsoft Excel
Microsoft Office
Leadership
Teamwork
Research
Microsoft Word
PowerPoint
Data Analysis
Financial Analysis
Social Media

Education

Lists including Pavan

AM
AR
AG
AH

Based in NYC

2599 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

NY
New York University

2022

  • Board Member, NYU Innovation Venture Fund

    2022

    NYU's pre/seed-stage venture capital fund invests in startups founded by, and/or commercializing technologies, innovations and intellectual property developed by, current NYU students, faculty, and researchers.

DM
Digital Medicine Society (DiMe)

2019

  • Strategic Advisory Board

    2019

    The Digital Medicine Society (DiMe) is a professional society serving individuals at the intersection of the global healthcare and technology communities. DiMe supports the development of digital medicine through interdisciplinary collaboration, research, teaching, and the promotion of best practices.

AV
Arkitekt Ventures

2018 - 2025

  • Venture Partner

    2025 - 2025

  • Partner

    2021 - 2025

  • Venture Partner

    2020 - 2021

  • Senior Associate

    2020 - 2020

  • Investment Associate

    2018 - 2020

JH
Jimini Health

2023 - 2025

  • Investor

    2023 - 2025

    Jimini Health is creating a radically better mental health experience for patients with mental health conditions and improving outcomes through a combination of expert human therapists & clinically-integrated AI.

N
Nanite

2022 - 2025

  • Investor

    2022 - 2025

    Nanite is a next-generation non-viral gene delivery company developing a new class of programmable polymer nanoparticles for a range of modalities and indications. The company’s AI-driven platform, SAYER™, combines cutting-edge high-throughput experimental and computational methods to design fit-for-purpose delivery vehicles delivering a broad range of genetic cargoes with tissue specificity.

C
CertifyOS

2021 - 2025

  • Investor

    2021 - 2025

    CertifyOS is an API-first, UI agnostic, end-to-end network management platform for provider credentialing, enrollment, monitoring and licensing.

HH
Handspring Health

2021 - 2025

  • Investor

    2021 - 2025

    Handspring Health provides quality and evidence-based mental healthcare for children.

Q
QSimulate

2021 - 2025

  • Investor

    2021 - 2025

    QSimulate revolutionizes industry R&D with innovative quantum simulations to make meaningful contributions to the drug discovery process.

R
Rx.Health

2016 - 2023

  • Co-Founder, VP of Corporate & Business Development (Acq. by Commure)

    2016 - 2023

    Rx.Health was acquired by Commure in 2023. Served as VP of Business Development from 2016-2018. The platform we built has powered over 30M patient interactions and engages over 300,000 patients daily. Rx.Health is now Commure Engage

OS
Old Silver VC

2020 - 2023

  • Advisor

    2020 - 2023

    Old Silver VC is an evergreen Langer family associated fund that makes early-stage investments in Biotech, Digital Health, AI, and Material Sciences.